Nationwide survey of 10mg/kg biweekly bevacizumab in combination with chemotherapy for the treatment of platinum-resistant ovarian cancer in Japan
Latest Information Update: 08 Sep 2020
At a glance
- Drugs Bevacizumab (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Sep 2020 New trial record